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Abstract
Advance care planning (ACP) is a framework used to describe the process of end-oflife care planning. ACP includes four behaviors: completing a living will that
documents end-of-life wishes, appointing a health care proxy (HCP), discussing the
use of interventions with loved ones, and discussing quality versus quantity of life
with loved ones. Studies have found that the number of individuals engaging in ACP
is low. Further, even those who have completed a living will and HCP often have
insufficient communication with loved ones regarding their end-of-life wishes, often
leading to discordant end-of-life care. The present study used constructs from the
Transtheoretical Model (TTM) to examine predictors associated with surrogates’ (N=
216) readiness (i.e., Stage of Change) to help their loved one complete ACP behaviors.
Exploratory analyses including Analyses of Variance (ANOVAs) and correlations
examined surrogate age, race, gender, experience with medical decision making
relationship to the older patient, frequency of contact, perceived positive consequences
of ACP behaviors (Pros), perceived negative consequence of ACP behaviors (Cons),
and ACP attitudes values and cultural beliefs (AVCB) as potential predictors of
surrogate readiness to assist their loved one in the four ACP behaviors. A series of
multiple regressions showed that across the four ACP behaviors, only Cons was a
significant predictor of Stage of Change, suggesting that as surrogates perceived more
negative consequences of ACP, they were less ready to support the older patient in the
process. This result is not consistent with other TTM research, in which Pros and Self
Efficacy are generally stronger predictors of Stage of Change. This study also
examines the level of agreement between older patients and their surrogates on
readiness to engage in the four ACP behaviors. Difference scores between the

surrogate Stages of Change and that of their older patient counterpart reflected
discrepancies in readiness for ACP behaviors. ANOVAs and correlations were used to
examine relationships between the level of agreement and the surrogate variables.
Stage of Change distributions revealed surrogates were more ready to participate in
ACP behaviors than the older patients, indicating that surrogates may play an
important role in older patients’ readiness to complete ACP behaviors. Increased
surrogate age was associated with less agreement on readiness to engage in creating a
living will. Female gender and higher surrogate ratings on Pros was associated with
more agreement in discussing interventions. Higher surrogate ratings of Cons was
significantly associated with less agreement to discuss interventions, and more
agreement to discuss quality versus quantity of life. Higher ratings on AVCB was
significantly associated with less agreement in readiness to discuss interventions.
Future longitudinal research may provide more information regarding these
relationships.
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Introduction
Current medical interventions, such as the use of life-sustaining machines,
have the potential to prolong life far beyond the point at which an individual would
live in the absence of these interventions. The use of these interventions often results
in end-of-life care that is costly and exceeds the amount and duration of medical
interventions the patient wished to receive (Zhang, 2009). Thus our intervention
driven medical culture tends to put patients, their physicians, and their loved ones in a
position of extending quantity of life at the expense of quality of life. Therefore, it is
important for all involved in end-of-life care to consider the costs and benefits of life
sustaining medical technologies. Research suggests that fewer life sustaining
interventions could lead to better end-of-life outcomes. For example, Cohen et al.
(2011) analyzed 701 retrospective reports from physicians of deceased patients in
Brussels, Belgium and found that overall, patients who received palliative care
services (i.e. services that aim to allay discomfort at end-of-life rather than attempting
to prolong life) had greater feelings of well-being as measured by the Edmonton
Symptom Assessment System (ESAS) as well as less shortness of breath, implying
that they experienced less anxiety than those who did not receive palliative care. In
addition, it was found that patients who received palliative care were more likely to
die in the setting they preferred (i.e. mostly within the home) than those who did not
receive palliative care (Cohen et al., 2011). These findings suggest that patients who
received palliative care were more likely to have their preferences followed at end-oflife care. In order to receive the desired form of end-of-life care, the patient must
explicitly make their wishes known to their loved ones and physician. The appropriate
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steps that are taken to accomplish this include the following: creating a living will (a
document that includes end-of-life care wishes), and appointing a healthcare proxy
(HCP), a patient advocate who ensures that physicians adhere to patient wishes. This
process is described as Advance Care Planning (ACP), in which a patient can prepare
for a time that they may be unable to communicate their healthcare preferences
regarding the utilization of life-prolonging machines and procedures or palliative care.
A recent study that examined the need for ACP in medical settings found that out of
1083 hospitalized older patients, up to 57.2% required medical decision making by a
surrogate and only 7.4% of the sample had a living will and 25% had an HCP
document in their medical record (Torke et al., 2014). These findings highlight the
current need for ACP completion in older patient populations.
ACP is best not thought of as a static process in which one’s preferences
remain constant throughout changing circumstances. It is important for all involved in
the process to understand the older patient’s preferences as they may shift and evolve,
which requires adequate and continuous communication. Current research suggests
that poor communication between a patient, their physician, and loved ones (i.e.
surrogates) regarding end-of-life care typically results in care that is discordant with
patient wishes (Swetz, Kuczewski, & Mueller, 2011). Therefore, in addition to
completing documentation, the patient continuing to communicate their wishes to
physicians and loved ones should improve the likelihood that they will receive the
end-of-life care they desire (Hines, Toale, Heisel, & Baringer, 2000; Swetz et al.,
2011). In addition to creating a living will and HCP, communication between the
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patient and surrogate, as well as communication between the patient and physician has
been regarded as an important component of ACP (Fried et al., 2010).
Justification and Significance of the Study
The current literature on ACP and quality-of-life (QOL) ratings is mainly
concerned with agreement between the patient and their HCP regarding end-of-life
preferences (Capelle,Vlak, Algra,& Rinkel, 2010; Essen, 2004; Fried et al., 2011;
Hawkins, Ditto, Danks, & Smucker, 2005; Hines et al., 2000; Jette et al., 2012; Parks
et al., 2011; Rothman et al., 1991; Seckler, Meier, Mulvihill, & Paris, 1991;
Shalowitz, Garrett-Mayer, & Wendler, 2006; Swetz et al., 2011; Winters & Parks,
2008). This research found that while surrogate ratings of patient QOL and physical
ability (e.g. ambulatory abilities) are reasonably accurate, surrogate-patient agreement
on advance care preferences is poor. It appears that surrogates have better
understanding of their loved one’s physical health rather than their preferences for
treatment at end-of-life care. Further, while ACP improves end-of-life care outcomes
for patients and their families, communication regarding this process between patients
and their surrogates and physicians is lacking (Patel, Janssen,& Curtis, 2011). Thus,
research is needed in order to understand factors associated with the level of surrogate
involvement in ACP for a loved one.
Currently, no research specifically examines factors that potentially predict
surrogates’ readiness to assist a loved one in ACP. The present study attempts to
address this question by using Multiple Regression modeling to assess whether
demographics (i.e. age, race, gender, and relationship to older patient), frequency of
interaction with the older patient, medical experiences, and Pros and Cons can
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adequately predict readiness to assist an older patient in ACP. In addition, these
predictors of surrogate readiness to help an older patient will be analyzed as predictors
of agreement between the surrogates and their loved ones on readiness to complete
(older patient) or assist (surrogate) in completion of ACP behaviors. In the present
study, agreement is defined as the level of discrepancy between older patient-surrogate
readiness to complete (i.e., Stage of Change) in the ACP behaviors. Previous analysis
on these data showed that agreement between older patients and surrogates on
completion of a living will document was high (81%), while agreement on the other
ACP behaviors were fair to poor: completion of a healthcare proxy (68%),
communication regarding the older patient’s views on life-sustaining treatment (64%),
and communication regarding quality versus quantity of life (62%) (Fried, Redding,
Robbins, O’Leary, & Iannone, 2011). These findings are limited in that they were
assessed from ‘yes’/’no’ answers; thus, analyzing the predictors associated with these
findings on agreement would add depth and clarity to understanding of the surrogate
role in ACP.
Research suggests there are gaps in surrogate understanding of their loved one’s
end-of-life wishes that can be addressed with effective communication. Insufficient
surrogate-patient communication can lead to multiple problems in end-of-life care.
Studies have shown that physician decision making when the patient is unable to
communicate near end-of-life results in care that is typically discordant with patient
wishes (Shalowitz et al., 2006; Torke, Moloney, Siegler, Abalos, & Alexander, 2010).
Although physicians typically express that they view patient preferences as important,
there is evidence that suggests the presence of a living will, patient-physician
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discussions regarding end-of-life treatment, and physicians’ personal beliefs on the
subject do not significantly predict physician adherence to patient preferences (Torke
et al., 2010). Given that physicians will typically act in favor of aggressive medical
care (e.g. the use of life sustaining procedures) regardless of whether it adheres to
patient wishes, it is important that the patient have a surrogate present to ensure that
care is concordant with the patient’s wishes. In summary, although surrogate decision
making is also imperfect, physician decision making in end-of-life treatment is often
more discordant with patient preferences (Shalowitz et al., 2006).
Even in the event that a surrogate is present, decisions made by surrogates are
often inaccurate due to insufficient communication between the patient and the
surrogate as well as overconfidence in both the patients and surrogates regarding
surrogate decision-making accuracy (Hawkins et al., 2005; Hines et al., 2000;
Shalowitz et al., 2006; Swetz et al. 2011). Although living will documents are an
important component in ACP, designations are often rigid and can be difficult to
interpret in ambiguous situations. For example, Mahon (2011) explains that a patient
may consider a treatment if it will improve health, but may refuse the same treatment
if it will prolong life at the expense of QOL. A surrogate who can accurately report the
patient’s wishes would be essential in this circumstance. Moreover, research suggests
that patients’ advance care preferences change significantly overtime, corresponding
with changes in health and perspectives regarding quality versus quantity of life (Fried
et al., 2007). Evidence suggesting that ACP is a dynamic process, further emphasizes
the importance of effective and continuous surrogate-patient communication.
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Although research on the effects of improved communication on ACP readiness is
limited, the extant literature suggests that when patient-surrogate communication is
sufficient, surrogate involvement in the process of ACP can improve understanding of
patient end-of-life care preferences and improve adherence to the patient’s wishes,
thus allaying some of the stress and burden associated with difficult medical decision
making that is experienced by all involved. The current literature on ACP supports the
argument that older patient-surrogate communication is as important in ACP as
completing a living will and HCP (Hines, et al., 2000; Shalowitz et al., 2006;Swetz et
al., 2011; Torke, et al., 2010). In the present study, communication regarding the use
of life sustaining interventions and communication regarding quality versus quantity
of life are included as two behaviors that are relevant to ACP. In summary,
communication plays an important role in ACP and the present study attempts to
examine this factor by assessing a frequency of contact measure as a predictor of
surrogate readiness to assist their loved one in ACP and agreement in Stage of Change
of the four ACP behaviors (i.e. creating a living will, creating a HCP, communicating
preferences regarding the use of life sustaining treatments, and communication
regarding quality versus quantity of life).
Programs aimed at raising awareness of the importance of ACP in patients nearing
end-of-life can improve quality of death by ensuring that patients’ medical wishes are
followed (Fried et al., 2012; Levy, Morris, & Kramer, 2008). However, older patients
often approach end-of-life without ensuring that their advance care wishes are known
through a living will or advance directive, a HCP, or through adequate communication
with surrogates and physicians. Although patients often view ACP in a positive light,
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rates of completion of living wills and HCP are low (Salmond & Estrella, 2005;
Silveira, Kim, & Langa, 2010). More specifically, Silveira et al. (2010) reviewed
medical records of 3746 subjects (≥ 60-years-old) and found that individuals who
completed a living will were more likely to request limited care and those who
completed a HCP were more likely to die outside of the hospital. Further, patients who
did not complete a living will or HCP were more likely to receive aggressive care at
end-of-life in a hospital. In summary, older patients who do not make their wishes
known by completing ACP and communicating their wishes to physicians and loved
ones could potentially receive end-of-life care that is more aggressive than they might
prefer. This information highlights the importance of understanding factors associated
with successful completion of ACP. More importantly, with completion rates of ACP
being unacceptably low (Silveira et al., 2010, Torke et al., 2014), surrogate aid in the
process of completing a living will and HCP could improve end-of-life care outcomes.
Therefore, it is important that the present study examine factors that could serve as
predictors of surrogate readiness to assist an older patient in completing a living will
and HCP.
Transtheoretical Model
The Transtheoretical model (TTM) is a comprehensive and integrative model of
behavior change that has been applied as an organizing framework to understand
behavior change and decision-making in dozens of contexts (Prochaska et al., 1994).
The following key constructs are included in the TTM: Stages of Change, Decisional
Balance, Self-efficacy and Processes of Change. The Stages of Change construct is
based on a series of stages that individuals tend to move through in efforts to achieve
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behavior change (Prochaska et al., 1994). The Decisional Balance construct was
adapted from Janis and Mann’s (1977) decision making model. This construct is
essentially a decisional balance checklist of comparative gains (Pros) and losses
(Cons) (Prochaska et al., 1994). The Self Efficacy construct was derived from
Bandura (1977) and this term refers to an individual’s confidence in their ability to
complete a behavior. The Processes of Change construct is aimed to examine
behaviors that represent activities that people use to progress through the Stages of
Change; these include experiential and cognitive processes (e.g. consciousness raising
and self-reevaluation), which are used in the earlier stages, and behavioral processes
(e.g. helping relationships and self-liberation), which are used in later stages (Fried et
al. 2010). The TTM has shown consistent results when applied to 48 different health
behaviors in 10 different countries (Hall and Rossi, 2008), indicating that the TTM is
generalizable as a model for behavior change across many different groups. Moreover,
the TTM Stages of Change have been used as a conceptual framework for social
workers discussing advance care planning with patients that had advanced illnesses
(Rizzo et al., 2010).
Fried and colleagues (2012) were the first to develop and validate scales that
measure the TTM constructs as applied to ACP behaviors in a sample of older
patients. In the present study, two key constructs of the TTM will be analyzed:
Decisional Balance and Stage of Change. The Stages of Change range from a stage
that indicates that a participant is not considering changing a behavior to a stage that
indicates the participant has performed the behavior more than 6 months prior.
Precontemplation defines the stage in which an individual is not planning on changing
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a behavior in the foreseeable future (i.e. within the next 6 months). Contemplation is
the stage that indicates an individual is planning to take steps toward behavior change
in the next 6 months. Preparation is characterized by an individual planning to change
a behavior in the more immediate future (i.e. within the next 30 days). Action is the
stage that indicates an individual has made behavior changes within the preceding 6
months. Maintenance is a stage that indicates an individual is continuing the desired
behavior; in the context of the present study, Maintenance describes an individual who
completed ACP documentation and communicated their preferences to surrogates
prior to 6 months (Fried et al., 2010). The Decisional Balance construct (Pros and
Cons) is an intermediate indicator of change, meaning that there is a consistent
relationship between the level of Pros and Cons and Stage of Change: as individuals
progress from Precontemplation to action, the maximum increase in Pros is typically
twice the maximum decrease in Cons (Hall and Rossi, 2008).
Given that TTM constructs have shown consistent results across many different
behaviors, including the context of ACP (Fried et al., 2012), this model of behavior
change would be an appropriate framework for understanding readiness to complete
ACP behaviors. In the present study, the (TTM) Stages of Change were used in the
surrogate sample to assess readiness to help an older patient in ACP (Fried et al.,
2010). Based on questions regarding thoughts on ACP completion behaviors,
participants were placed into their respective Stage of Change (i.e. Precontemplation,
Contemplation, Preparation, Action/Maintenance). Surrogates were also asked a series
of questions regarding the Pros and Cons of helping a loved one complete ACP.
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Predictors of Surrogate Stage of Change
Based on previous findings, several independent variables can be tested as
predictors of Stage of Change for each of the four ACP behaviors in the present study.
Surrogate Age and Gender. Evidence suggesting that age and gender play a
role in surrogate ACP involvement is scarce. However, Hines and colleagues (2000)
found that of the patients who chose a parent as surrogate, mothers were chosen
significantly more often (78%) than fathers (22%). Additionally, although the gender
differences in other categories (i.e. spouse, child, sibling, and friend) were not
significant, the overall frequency of females in the Hines et al. (2000) study was
higher than males. The greater frequency of female surrogates might suggest that
females in the present study will be more likely to be at a later stage of readiness for
ACP than males. In addition, Alano and colleagues (2010) examined predictors
associated with completion of advance directives in a sample of older adults (> 65years-old) and found that significantly more females completed advance directives
than males. Although this finding is not derived from a surrogate sample, it suggests
the likelihood that females will participate in ACP is higher than males. It was also
found that increased age was a predictor of completion of an advance directive (Alano
et al., 2010). For example, participants that were above age 85 were 6.3 times more
likely to complete an advance directive than participants 59-75 years old. These results
suggest that increased age in the surrogate sample may be associated with greater
likelihood of being at a later Stage of Change to assist a loved one in ACP.
Surrogate Race. It is expected that race will be a significant predictor of Stage
of Change in each of the four ACP behaviors. More specifically, Whites will have
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greater likelihood of being in a later Stage of Change than Nonwhites. Hopp & Duffy
(2000) used logistic regression to compare differences in ACP and end-of-life care
decision making amongst Whites and Blacks. Results from this study showed that
Whites were significantly more likely to discuss ACP with loved ones, complete a
living will, and appoint a HCP. In addition, Fried and colleagues (2010) found that, in
a sample of old patients (≥ 65-years-old), the majority of Whites were in the
Action/Maintenance Stage of Change (54%), while the majority of Nonwhites were in
the Precontemplation Stage of Change (59%). These findings suggests that the
likelihood of White surrogates discussing ACP and assisting older patients in the
planning process will be higher than Nonwhites in this study.
Surrogate-Older Patient Relationship. Research comparing the accuracy of
surrogates with different relationships to the older patient, specifically between
children and spouses, found that spouses are more likely to be chosen as a HCP and
are significantly more accurate than children in following patient preferences at endof-life (Parks et al., 2011). Although there is currently no research specifically
comparing spouse and child readiness to assist in the ACP process, evidence was
found that the frequency of spouses serving as surrogates was significantly greater
(55%) than adult children (23%) (Hines et al., 2000). These findings suggest that in
the present study, it is likely that spouses will be at a later Stage of Change for ACP
behaviors than children of older participants.
Surrogate-Older Patient Communication. The literature on ACP suggests
that communication is a key component of surrogate accuracy and comfort with the
topic (Fried & O’Leary, 2008; Hines et al., 2000; Lang & Quill, 2004). This research
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implies that surrogates who have nuanced understanding of the older patient’s end-oflife wishes will be more willing to assist that person in ACP. It is expected that
surrogates who communicate more often with their loved one will have greater
likelihood of being involved with assisting the older patient in each of the four ACP
behaviors.
Surrogate Life Experience with Medical Decisions. Medical experiences
might serve as predictors of readiness to assist a loved one in ACP. Previous research
has identified that experience of major surgery makes old adults’ completion of
advance directives six times more likely to occur (Alano et al., 2010), suggesting that
surrogates with more medical experiences in the present study will have greater
likelihood of being at a later Stage of Change in readiness to assist in ACP. Further, in
a study assessing factors that help or hamper surrogates’ willingness to assist an older
loved one in ACP found that previous experience with medical decision making is a
factor that helps surrogates in this process (Vig et al., 2007).
Surrogate Pros and Cons. It is expected that endorsements in the Decisional
Balance construct of the TTM will serve as predictors of Stage of Change. More
specifically, previous research examining the validity and reliability of the TTM in
ACP behavior change on a sample of older adults (≥ 65-years-old), found that an
increase in Pros and a decrease in Cons of ACP was associated with increased
readiness in ACP participation (Fried et al., 2012). It is expected that results from the
present study will be consistent with results from the Fried and colleagues (2012)
study in that increased Pros and decreased Cons will be associated with later Stages of
Change (i.e. greater readiness to help a loved one in ACP behaviors).

12

Surrogate Attitudes Values and Cultural Beliefs (AVCB). Medical
misconceptions as well as religious beliefs that regard a higher power as the entity that
determines health outcomes have been shown to influence medical decision making,
particularly in the context of organ donation and ACP. In a review examining the
cultural influences on African American’s willingness to become an organ donor,
Morgan (2006) highlights the common medical misconceptions and religious beliefs
that influence the decision to become an organ donor. The view that physicians will
not save the lives of those who declare themselves as organ donors is a common
medical belief that discourages organ donation in African Americans. Further,
religiosity can influence the decision to donate organs in two ways: religious leaders
might not emphasize the importance of certain health behaviors, and religious myths
might discourage certain health behaviors (Morgan, 2006). Similar misconceptions
have also been found to deter blood donation (Burditt et al., 2009).Given that medical
mistrust and misconceptions seem to be a barrier to health care planning, Fried and
colleagues (2012) developed the ACP Values and Beliefs scale (AVCB) that will be
analyzed in the present study. This scale incudes items that inquire about the
misconceptions and attitudes that might deter individuals from completing ACP. Fried
and colleagues (2012) found that in a sample of 304 older patients, ACP values and
beliefs are significantly associated with Stages of Change, which measure readiness to
complete all ACP behaviors. Given these previous findings, it is reasonable to predict
that this scale will show similar associations to Stages of Change in the surrogate
sample.
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Surrogate-Older Patient Discrepancy on Stage of Change
In addition to examining predictors of surrogate Stage of Change in each ACP
behavior, the present research aims to examine factors associated with surrogate-older
patient discrepancy. This set of analyses will describe the nature of the relationships
between variables including surrogate age, gender, race, relationship with the older
patient (Relationship), frequency of contact with the loved one (Communication),
experiences with medical decision making (Life Experience), Pros, Cons, AVCB, and
surrogate-older patient discrepancy on Stage of Change in each of the four ACP
behaviors.
Hypotheses
The present study attempts to further understand the factors associated with
surrogate involvement in ACP by examining potential predictors of surrogate
readiness to assist a loved one in ACP behaviors as well as better understanding the
relationships between surrogate-older patient discrepancies on the level of readiness
for completion of ACP behaviors and the predictor variables. ANOVAs and Chisquare tests will be used as exploratory analyses to test group differences between the
predictor variables and Stage of Change as well as the surrogate-older patient
discrepancy on Stage of Change in each of the four ACP behaviors. Multiple
Regression analyses will be used to assess whether variables such as age, race, gender,
Relationship, Communication, Life Experience, Pros and Cons, and AVCB, can
predict surrogate readiness to assist a loved one in ACP behaviors. The following
hypotheses will be tested:
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1. Predictors of surrogate readiness to assist a loved one (i.e. Stage of Change) in
each of the four ACP behaviors will include the following: a spousal
relationship to the older patient, interacting with the older patient daily, White
race, female gender, increased age, greater experience with medical decision
making, increased Pros, and less religious and medical misconceptions related
to end-of-life care.
2. Exploratory analyses will be run in order to elucidate the relationship between
the surrogate variables, which include age, gender, race, Relationship,
Communication, Life Experience, Pros, Cons, and AVCB, and the surrogateolder patient Discrepancy variable.
Methods
Participants and Recruitment
Data for the present study were collected from 218 older patients and their
surrogate, who was identified by the older patient, from two primary care facilities and
one senior center. Older patients in this study were screened by physicians as not
having a diagnosis of dementia. Trained interviewers conducted in-person interviews
with the older patients, as well as phone interviews with the surrogates. Of note, while
a total of 304 older patients participated in this study, roughly two thirds of this
sample identified a surrogate who subsequently agreed to participation. In addition,
the majority (i.e. approximately two thirds) of the older patients who identified
surrogates were in the Action/Maintenance Stage of Change across the four ACP
behaviors.
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Measures
The following measures were developed by Fried and colleagues (2010).
Although these measures were tailored for administration to the respective samples,
they were only validated in the older patient sample; not the surrogate sample (Fried et
al. 2010, 2012).
Descriptive Information. Demographic information was collected, which
includes age, race, gender, and the relationship with the older patient (i.e. Child,
Spouse, Significant other, or Other relationship). In addition, surrogates reported the
frequency of contact with the older patient as a proxy measure for the amount of older
patient-surrogate communication.
Surrogate Age and Gender. The older patients had a mean age of 75 (SD= ±
7) and the majority of the older patient sample were female (73%). The surrogate
sample had a mean age of 60 (SD=± 12.7) and were also majority female (68%).
Surrogate Race. The majority of the older patients were White (74%).
Surrogates endorsed one of three different racial/ethnic categories: White, Black, and
Other race. Sixty-nine percent of the sample identified as White, 26% identified as
Black, and 5% identified as Other race. Given that the Other race category made up a
small portion of the sample, race was dichotomized into White and Nonwhite
categories After dichotomizing this variable, Whites made up 69% of the surrogate
sample (N= 151), and Nonwhites made up 31% (N= 67).
Surrogate-Older Patient Relationship. Surrogates endorsed one of five
different relationships to the older patient categories: Child (42%), Spouse (40%),
Significant other (1%), Other relative (12%), and Other (5%). For analysis purposes,

16

these categories were collapsed into three groups: Child, Spouse and Other. Other
relative and Significant other categories represented a small percentage of the sample
(6%); therefore, it was determined that collapsing these categories with the Other
relative category would be appropriate. After categorizing relationships into three
groups, spouses made up 40% of the sample (N= 88), children made up 42% (N= 92),
and other relationships made up 18% (N= 38).
Surrogate-Older Patient Communication. Surrogates endorsed one of three
different frequency of contact (with the older patient) categories: Daily (76%), Weekly
(19%), and Less than weekly (4%). Given that those surrogates who contacted the
older patient less than weekly only made up 4% of the sample, the frequency of
contact categories were dichotomized into Daily and Weekly or less. Surrogates who
had daily contact with the older patient constituted 76% of the sample (N= 167) and
24% of the sample (N=51) contacted the older patient weekly or less.
The goal for collapsing the above described independent variable categories is
to address limitations in sample size in some participant subgroups and to improve the
statistical power of the analyses. Table 1 presents the demographic information of the
older patient and surrogate samples.
Surrogate Life Experience with Medical Decisions. A series of six questions
was used to assess surrogates’ prior experiences with medical experiences and
decision making. The surrogates were asked if they have experienced medical
problems themselves or if they have witnessed others experience medical problems or
had to make difficult medical decisions for others. The Life Experience index includes
items such as, “Have you ever faced a life-threatening illness?” and “Have you ever
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had to make a medical decision for someone who was dying?” Participants were asked
to respond ‘Yes’ or ‘No’ to each item. See Appendix A for a complete list of the Life
Experience items. These items were not formally developed as a scale and as such
internal consistency was modest (α= .48). The items were summed and treated as an
index and used as a predictor variable for the present analyses.
Older Patient Stage of Change. The ACP behaviors assessed in the older
patient sample are similar to those assessed in the surrogate sample. The four ACP
behaviors assessed in the older patient sample include the following: creating a living
will (Living Will), creating a Health Care Proxy (HCP), talking to friends and family
about end-of-life care interventions (Interventions), and talking to friends and family
about quality versus quantity of life (Quality vs. Quantity of Life). A Stage of Change
algorithm, similar to the above described algorithm for the surrogate sample, was
defined for each ACP behavior and older patients rated their readiness to complete
each of the four behaviors. Table 2 includes the frequencies of Stage of Change in the
surrogate and older patient samples as well as the difference between the percentage of
surrogates and older patients in each Stage of Change within the four ACP behaviors.
Surrogate Stage of Change. While the assessments of readiness to complete
ACP behaviors in the older patients focus on their own readiness to complete the ACP
behaviors, the surrogates are asked about their readiness to assist an older patient in
completing the four behaviors. A Stage of Change algorithm was defined for each
ACP behavior and surrogates rated their readiness to help the loved one in creating a
living will (Living Will), help the loved one in creating a Health Care Proxy (HCP),
talk to the loved one about end-of-life care interventions (Interventions), and talk to
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the loved one about quality versus quantity of life (Quality vs. Quantity of Life). For
each algorithm, surrogates rated their readiness on a four point scale from
with1=Precontemplation (e.g., I am not ready ),2=Contemplation (e.g., I am thinking
about helping/talking to my loved one in the next 6 months), 3=Preparation (e.g., I am
planning on helping/talking to my loved one in the next 30 days), or
4=Action/Maintenance (e.g., I have helped/talked to my loved one within the past 6
months or more.)See Appendix D for the measure that assessed participants’ Stage of
Change for each ACP behavior in the surrogate sample.
Surrogate-Older Patient Discrepancy on Stage of Change. The level of
discrepancy between the Stage of Change of the older patient and their surrogate was
determined by subtracting the surrogate Stage of Change from the older patient Stage
of Change; thus, 0 indicates no discrepancy (Optimal Agreement), 1 indicates (Good
Agreement), 2 indicates (Low Agreement) and 3 indicates the highest level of
discrepancy (No Agreement). This measure only reveals the level of surrogate-older
patient discrepancy on Stages of Change; not the nature of the discrepancy. For
example, a surrogate-older patient pair could show Optimal Agreement in an ACP
behavior if both are in the Precontemplation Stage of Change or if both are in the
Action/Maintenance Stage of Change. A discrepancy (i.e. a value of 1, 2, or 3) shows
the level of discordance between the surrogate and older patient on their readiness to
complete a given ACP behavior, but it does not describe which participant (i.e. the
surrogate or the older patient) is in each Stage of Change. Discrepancy will be
analyzed as a continuous measure. Table 3 provides descriptive statistics for
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Discrepancy in surrogate-older patient Stage of Change in each of the four ACP
behaviors.
Surrogate Decisional Balance (Pros and Cons). The Decisional Balance
measure included 6 Pros (i.e., the perceived benefits) and 6 Cons (i.e. the perceived
limitations) of assisting a loved one in ACP. These items were rated on a 5 point scale
from 1=”Strongly Agree” to 5=”Strongly Disagree”. Items are listed in Appendix B.
This sample indicated good reliability for Pros (α=.88) and Cons (α=.84).
Surrogate AVCB. The AVCB measure includes 7 items that assess religious
beliefs and medical myths associated with ACP. Surrogates endorsed these items on a
5-point scale assessing the level of agreement with each statement with 1 representing
‘Strongly Agree’ and 5 ‘Strongly Disagree.’ Chronbach’s alpha indicates good internal
consistency (α= .86).The AVCB items include “My loved one does not need to do
advance care planning because once you reach a certain age, the doctors aren’t going
to use machines,” and “My loved one does not need to do advance care planning
because once it becomes clear that you are dying, the doctors aren’t going to use
machines.” See Appendix C for the AVCB items. Table 4 includes the Chronbach’s
alphas for Life Experiences, Pros, Cons, and AVCB. Correlations amongst these
measures can be found in Table 5. Figure 1 illustrates the distribution of surrogate
ratings of Pros, Cons, and AVCB across Stages of Change in each of the four ACP
behaviors.
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Hypothesis I: Predictors of Surrogate Stage of Change
Methods
For exploratory analyses, a series of one-way ANOVAs were used to compare
older patients to surrogates on the continuous variables, which include age, Life
Experience, Pros, Cons, and AVCB, by Stage of Change for each of the four ACP
algorithms: Living Will, HCP, Interventions, and Quality vs. Quantity of Life. A
series of chi-square tests compared the older patients to surrogates for categorical
variables, which include race, gender, Relationship, and Communication, by Stage of
Change for each of the four ACP algorithms. Variables that showed significant group
differences across Stage of Change in any of the four ACP behaviors were entered into
the Multiple Regressions analyses. All statistics were run using IBM SPSS Statistics
version 20.
Results
Exploratory Analyses.
Living Will. Significant group differences among the Stages of Change for
creating a Living Will, were found for Pros F(3, 209)= 8.99, p<.001, η²= .114. Post
hoc analyses using Tukey HSD tests indicated that participants in Precontemplation
(M= 39.79, SD= 9.34) rated the Pros as significantly less important than those in
Preparation (M= 53.33, SD= 8.61) and Action/Maintenance (M= 50.96, SD= 9.81),
both p< .001. In addition, participants in Contemplation (M= 46.99, SD= 9.41) rated
Pros significantly lower than those in Preparation, p=.024.
Significant differences among Stages of Change were found in Cons F(3,
194)= 22.13, p<.001, η²= .225. Post hoc analyses using Tukey HSD tests indicated
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that participants in Precontemplation (M= 64.85, SD= 8.07) rated the Cons
significantly as more important than those in Preparation (M= 48.27, SD= 9.61) and
Action/Maintenance (M= 47.21, SD= 8.02), both p< .001.In addition, participants in
Contemplation (M= 57.07, SD= 10.14) rated Cons significantly higher than those in
Preparation and Action/Maintenance, both p< .001.
Significant differences among Stages of Change were found for AVCB F(3,
194)= 3.34, p=.02, η²= .049. Post Hoc analyses using Tukey HSD tests indicated that
participants in Precontemplation (M= 57.71, SD= 7.33) endorsed a significantly
higher level of concerns and myths about ACP than those in Preparation (M= 48.91,
SD= 10.26), p= .046, and Action/Maintenance (M= 49.11, SD= 9.80), p= .031. Table
6 shows the ANOVA results for surrogate ratings on Pros, Cons, and AVCB by Stage
of Change for the Living Will behavior.
No significant group differences among Stages of Change for creating a living
will were found on age, race, gender, Relationship, Communication, and Life
Experience.
HCP. Significant group differences among Stages of Change for naming a
HCP, were found for Pros F(3, 209)= 4.83, p=.003, η²= .065. Post hoc analyses using
Tukey HSD tests indicated that participants in Precontemplation (M= 38.18, SD=
8.41) rated Pros significantly lower than those in Contemplation (M= 49.15, SD=
8.28), p= .020, Preparation (M= 50.85, SD= 9.15), p=.003, and Action/Maintenance
(M= 50.85, SD= 10.35), p=.001. Table 7 presents the ANOVA results for surrogate
ratings on Pros and Cons by Stage of Change for the HCP behavior.
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Significant group differences among Stages of Change were found for Cons
F(3, 194)= 7.87, p<.001, η²= .109. Post hoc analyses using Tukey HSD tests indicated
participants in Precontemplation (M= 61.59, SD= 11.02) rated Cons significantly
higher than those in Preparation (M= 50.55, SD= 9.64), p=.040, and
Action/Maintenance (M= 48.01, SD= 9.69), p=.004. In addition, participants in
Contemplation (M= 56.10, SD= 7.99) rated Cons significantly higher than those in
Action/Maintenance, p=.001.
No significant group differences among Stages of Change for naming a HCP
were found for age, race, gender, Relationship, Communication Life Experience, and
AVCB.
Interventions. Significant group differences among Stages of Change for
talking to the loved one about end-of-life care interventions were found for Pros F(3,
210)= 7.17, p<.001, η²= .093. Post hoc analyses using Tukey HSD tests indicated that
participants in Precontemplation (M= 41.53, SD= 8.45) rated Pros significantly lower
than those in Preparation (M= 50.79, SD= 9.84), p= .017, and Action/Maintenance
(M= 51.32, SD= 9.28), p= .003. In addition, participants in Contemplation (M= 43.30,
SD= 12.31) rated Pros significantly lower than those in Preparation (M= 50.79, SD=
9.84), p= .042, and Action/Maintenance, p=.007.
Significant group differences among Stages of Change were found for Cons
F(3, 194)= 7.87, p<.001, η²= .109. Post Hoc analyses using Tukey HSD tests indicated
that participants in Precontemplation (M= 64.70, SD= 9.01) rated Cons significantly
higher than those in Preparation (M= 50.54, SD= 8.19) and Action/Maintenance (M=
48.01, SD= 9.24), both p< .001. In addition, participants in Contemplation (M= 58.64,
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SD= 9.08) rated Cons significantly higher than those in Preparation (M= 50.54, SD=
8.19), p= .029, and Action/Maintenance, p< .001. Table 8 shows the ANOVA results
for surrogate ratings on Pros and Cons by Stage of Change for the Interventions
behavior.
No significant group differences among Stages of Change for talking to the
loved one about end-of-life care interventions were found for age, race, gender,
Relationship, Communication, Life Experience, and AVCB.
Quality versus Quantity of Life. Significant group differences among Stages
of Change for talking to the loved one about quality versus quantity of life were found
for Pros F(3, 207)= 6.25, p<.001, η²= .083. Post hoc analyses using Tukey HSD tests
indicated that participants in Precontemplation (M= 41.02, SD= 7.76) rated Pros
significantly lower than those in Preparation (M= 50.91, SD= 9.80), p= .010, and
Action/Maintenance (M= 51.15, SD= 9.55), p= .002. In addition, participants in
Contemplation (M= 44.53, SD= 11.64) rated Pros significantly lower than those in
Action/Maintenance, p=.048.
Significant group differences among Stages of Change were found for Cons
F(3, 194)= 19.75, p<.001, η²= .234. Post hoc analyses using Tukey HSD tests
indicated that participants in Precontemplation (M= 68.35, SD= 4.42) rated Cons
significantly higher than those in Contemplation (M= 57.67, SD= 8.83), p= .024,
Preparation (M= 50.94, SD= 10.20), p< .001, and Action/Maintenance (M= 47.81,
SD= 8.72), p< .001. In addition, participants in Contemplation rated Cons
significantly higher than those in Action/Maintenance, p< .001.Table 9 shows the
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ANOVA results for surrogate ratings on Pros and Cons by Stage of Change for the
Quality versus Quantity of Life behavior.
No significant group differences among Stages of Change were found for age,
race, gender, Relationship, Communication Life Experience, and AVCB in the Quality
versus Quantity of Life behavior.
Multiple Regressions. Standard multiple regressions were run to examine
possible relationships between predictors and Stage of Change in each of the four ACP
behaviors. Only predictors that showed significant differences among Stage of Change
in each of the four ACP behaviors were entered into the regression models.
Living Will .A multiple regression was run including Pros, Cons, and AVCB
as predictors and Living Will ACP Stage of Change as the dependent variable. Cons
accounted for 23% of the variance, R² = .23, F(3, 185) = 18.181, p < .001, and was
found to be the only significant predictor of Living Will Stage of Change, β = .49, t(188) = -6.53, p < .001, indicating a significant negative relationship between
Cons and surrogate Stage of Change in the Living Will behavior.
HCP. A multiple regression was run including Pros and Cons as predictors and
HCP Stage of Change as the dependent variable. Cons accounted for 10% of the
variance, R² = .10 [F(2,195) = 11.24, p < .001], and was the only significant predictor
for Stage of Changeβ = -.32, t(197) = -4.11, p < .001, indicating a negative
relationship between Cons and surrogate Stage of Change in the HCP behavior.
Interventions. A multiple regression was run including Pros, and Cons as
predictors and Interventions Stage of Change as the dependent variable. Cons
accounted for 19% of the variance, R² = .19,F(2, 196) = 22.58, p < .001, and was the
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only significant predictor for Stage of Changeβ = -.38, t(198) = -5.09, p < .001,
indicating a significant negative relationship between Cons and surrogate Stage of
Change in the Interventions behavior.
Quality versus Quantity of Life. A multiple regression was run including Pros
and Cons as predictors and Quality vs. Quantity of Life Stage of Change as the
dependent variable. Cons accounted for 22% of the variance, R² = .22 [F(2, 195)
=27.18 , p < .001]indicating a significant negative relationship, β = -.46, t(197) 6.28, p
< .001,with surrogate Stage of Change in the Quality vs. Quantity of Life behavior.
Table 10 provides a summary of the multiple regression results for each of the four
ACP behaviors.
Hypothesis II: Exploratory Analyses of Surrogate-Older Patient
Discrepancy
Method
In this set of analyses, factors associated with the Discrepancy between older
patients and their surrogates Stage of Change within each of the four ACP behavior
staging algorithms are evaluated. A series of one-way Analysis of Variance (ANOVA)
models were used to compare differences in Discrepancy between surrogate-older
patient Stage of Change in each of the four ACP algorithms among race, gender,
Relationship, and Communication groups in each of the four ACP algorithms.
Correlations compared relationships with discrepancy and continuous variables, which
include age, Life Experience, Pros, Cons, and AVCB and Discrepancy (i.e. levels of
agreement) on Stages of Change in each of the four algorithms. In addition, Stage of
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Change distribution in the surrogate and older patients was evaluated in order to
examine patterns in overall readiness to complete each of the four ACP behaviors.
Results
As illustrated in Figure 2, across the four ACP behaviors, older patients
reported being less ready to complete ACP behaviors than the surrogate sample. For
example, comparison of Stage of Change distribution across the two samples in the
HCP behavior shows that more older patients were in Precontemplation (31.3%) and
Contemplation (7.6%), whereas more surrogates were in Preparation (15.4%) and
Action/Maintenance (23.7%). In addition to notable differences in the level of
readiness in the two groups, the overall distribution of Stage of Change shows that the
majority of participants are in Action/Maintenance, with the exception of older
patients in the HCP behavior.
Living Will. A significant positive correlation was found between Discrepancy
in the Living Will behavior and age, r(215) = .14, p = .040. No significant correlations
were found between Pros, Cons, and AVCB and Discrepancy. In addition, no
significant differences on Discrepancy were observed amongst, race, gender,
Relationship, and Communication in the Living Will behavior.
HCP. No significant correlations between age, Life Experience, Pros, Cons,
and AVCB, and Discrepancy on Stage of Change in the HCP behavior were found. In
addition, no significant differences on Discrepancy were observed amongst race,
gender, Relationship, and Communication groups in the HCP behavior
Interventions. A significant negative correlation was observed between
surrogate ratings on Pros and Discrepancy in the Intervention behavior, r(207) = -
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.56, p < .001. A significant positive correlation was observed between surrogate
ratings on Cons and Discrepancy, r(194) = .25, p = .001. In addition, a significant
positive correlation was found between Discrepancy and AVCB, r(193) = .31, p <
.001, in the Interventions behavior.
Significant group differences among gender groups were found in Discrepancy
on Stage of Change in the Interventions behavior, F(1, 208)= 5.95, p=.016, η²=
.028.Table 11 shows the ANOVA results for gender group differences on Discrepancy
of Stage of Change in Interventions.
Surrogate age and Life Experience were not significantly correlated with
Discrepancy on Stage of Change in the Interventions behavior. In addition, no
significant group differences among race, Relationship, and Communication were
found on Discrepancy.
Quality vs. Quantity of Life. A significant negative correlation was observed
between surrogate ratings on Cons and Discrepancy, r(188) = -.22, p = .002.
Age, Life Experience, Pros, and AVCB were not significantly correlated with
Discrepancy in the Quality versus Quantity of Life behavior. In addition, no
significant group differences among race, gender, Relationship, and Communication
were found on Discrepancy. Table 12 includes correlations between the continuous
independent variables and surrogate- older patient Discrepancy in readiness to
complete each of the four ACP behaviors.
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Discussion
Surrogate Readiness to Help a Loved One in ACP Behaviors
Medical interventions have the potential to prolong life far beyond the point at
which an individual would live in the absence of these interventions. Given that
medical interventions can be costly and often exceed the amount of care a patient
would wish to receive at end-of-life (Zhang, 2009), it is important that all involved in
end-of-life care decision making fully understand the patient's wishes through the
following ACP behaviors: completing a living will that documents end-of-life wishes
(Living Will), appointing a health care proxy (HCP), discussing the use of
interventions with loved ones (Interventions), and discussing quality versus quantity of
life with loved ones (Quality versus Quantity of Life). Studies have found that the
amount of individuals who have completed ACP is insufficient, and further, those who
have completed a living will and HCP often have insufficient communication with
loved ones regarding their end-of-life wishes, which often leads to discordant end-oflife care.
In order to further explore this issue, the present study examined predictors
associated with surrogate readiness to help a loved one in doing the four ACP
behaviors. The overall results did not support the hypothesis that age, race, gender,
Life Experience, Relationship, Communication, Pros, and AVCB would be significant
predictors of Stage of Change in all of the ACP behaviors. However, exploratory
analyses revealed that Pros, Cons, and AVCB were significantly associated with Stage
of Change in the Living Will behavior. Higher ratings on Pros was associated with
more surrogate readiness to help a loved one complete a living will document,
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whereas higher ratings on Cons and AVCB was associated with less surrogate
readiness to help a loved one complete a Living Will. Additionally, in the ACP
behaviors, HCP, Interventions, and Quality versus Quantity of Life, significant
differences were found among Stages of Change in Pros and Cons. In each of these
behaviors, higher ratings on Pros was associated with more surrogate readiness to help
a loved one complete HCP, discuss the use of end of life interventions as well as focus
on quality versus quantity of life with their loved one. Conversely, higher ratings on
Cons was associated with less readiness to help a loved one complete HCP, and
discuss the use of interventions as well as quality versus quantity of life with their
loved one. The association between increased Pros and greater surrogate readiness, as
well as the association between increased Cons and less surrogate readiness is
consistent with the relationships between Pros and Cons, and Stage of Change in the
older patient sample (Fried et al., 2012).
A significant predictor in each surrogate ACP behavior was Cons, or perceived
negative consequences of a given ACP behavior. These findings indicate that lower
ratings of Cons is associated with helping a loved one in each of the four ACP
behaviors. In other words, surrogates who perceived fewer negative consequences to
performing ACP were more ready to help an older patient (i.e. loved one) complete
and discuss ACP behaviors. This finding is consistent with previous research that
suggesting that ACP non-completers were more concerned with negative beliefs
associated with ACP (e.g. “advanced directives are too binding”) than ACP
completers (Beck, Brown, Boles, & Barret, 2002). It may be helpful for health care
providers to focus on addressing the negative aspects or Cons of ACP in their
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consultations with patients and their loved ones, thus promoting more surrogate
involvement in the ACP process. This is consistent with implications of the patient
perceived barriers to ACP examined by Schickedanz and colleagues (2009). This
finding is not consistent with previous TTM research across many behavioral
domains, which suggests that Pros are more strongly associated with readiness for
behavior change than are Cons (Hall & Rossi, 2008). Results from Schickedanz and
colleagues (2009) suggested six barrier themes that impeded patients from completing
ACP behaviors, which include the following: “perceiving ACP as irrelevant (84%);
personal barriers (53%); relationship concerns (46%); information needs (36%); health
encounter time constraints (29%), and problems with advance directives (29%). Some
barriers were endorsed at all steps (e.g., perceiving ACP as irrelevant). Others were
endorsed at individual steps (e.g., relationship concerns for family/friend discussions,
time constraints for doctor discussions, and problems with advance directives for
documentation)” (p. 5). Schickedanz and colleagues (2009) drew conclusions similar
to the present study regarding the importance for health care providers to address
barriers or perceived negative consequences of completing ACP behaviors. This
finding may have significant implications for the development of future intervention
programs in medical care settings.
Agreement on Readiness to Complete ACP Behaviors
Research suggests that insufficient communication between the older patient
and their surrogate often leads to end-of-life care that is discordant with patient wishes
(Shalowitz et al., 2006; Torke, Moloney, Siegler, Abalos, & Alexander, 2010). Given
that little is known regarding the factors that may contribute to this discordance, this
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set of analyses aimed to examine surrogate variables that may be associated with the
level of discrepancy among older patient-surrogate Stages of Change in each of the
four ACP behaviors. The difference in overall Stage of Change distribution between
the surrogates and older patients suggests that surrogates may be more willing to
participate in ACP behaviors than older patients. This implies that involving loved
ones in the ACP process may encourage older patients to complete ACP behaviors. In
comparison to other ACP behaviors, Stage of Change distributions suggest that older
patients may experience more difficulty in appointing an HCP, which further
implicates the importance of older patient communication with loved ones regarding
end-of-life care wishes. Reasons why these patterns of readiness are observed may be
elucidated in future research. These findings may also have implications for clinical
discussions.
Results indicated that age was significantly associated with Discrepancy in
surrogate-older patient Stage of Change in the Living Will behavior. More
specifically, older surrogates were more likely to have discordance with their loved
one in readiness to complete a living will. Given that the strength of this association
was relatively week, this result should be interpreted with caution. No surrogate
variables were found to be significantly associated with Discrepancy in readiness to
complete the HCP behavior.
In terms of Discrepancy on Stage of Change in the Interventions behavior,
results indicated that higher ratings on Pros was associated with more surrogate-older
patient agreement, whereas higher ratings of Cons and AVCB was associated with less
surrogate-older patient agreement. In addition, results indicate that female surrogates
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were more likely to be on the same level of readiness as their loved ones to discuss the
use of medical interventions at end-of-life care than male surrogates. Pros was
significantly associated with Discrepancy between surrogate and older patient Stage of
Change in Interventions, which suggests that surrogates who perceive more positive
consequences related to discussing medical interventions at end-of-life care were more
likely to be at the same level of readiness as their loved one to complete this behavior.
Surrogate ratings on Cons was significantly correlated with Discrepancy on
Stages of Change in the Quality versus Quantity of Life behavior, indicating that
surrogates who endorsed more perceived negative consequences of completing the
Quality versus Quantity of Life behavior were more likely to be on the same level of
readiness as their loved ones. Overall, results suggest that it may be helpful to address
perceived positive and negative aspects of ACP, as well as cultural beliefs that may
play a role in older persons’ readiness to communicate medical wishes with their loved
ones. However, given that these results are mixed, they should be interpreted with
caution.
Limitations
An important limitation of the present study is that the later Stages of Change
are over-represented in the surrogate sample in each of the ACP behaviors, with the
majority (i.e. ≥ 58%) of participants in the Action/Maintenance Stage of Change and a
small portion (i.e. < 8%) in the Precontemplation Stage of Change. This overrepresentation of later Stages of Change suggests that the present sample may
represent a subset of the general population of older persons and their loved ones, thus
the present findings may be limited in generalizability. Further, cross-sectional data is
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limiting with regard to understanding behavior change; therefore, results from the
present data can only indicate which factors may be relevant in longitudinal studies.
Although the scales utilized in the surrogate sample were validated in the older
patient sample (Fried et al. 2012), confirmatory factor analysis has not been performed
on these scales in the surrogate sample. Thus, the present results involving the
Decisional Balance and AVCB measures should be interpreted with caution. In
addition, the present study only examined predictor variables derived from the
surrogate sample. Examining variables from the older patient sample may provide
more information regarding predictors of surrogate Stage of Change as well as
Discrepancy on Stages of Change.
Another limitation in the present study is that the Discrepancy measure merely
reveals discordance between the surrogate and older patient Stage of Change in each
ACP behavior. This measure does not describe the nature of the discordance;
therefore, conclusions derived from this measure are limited. For example, although a
surrogate-older patient pair may have Optimal Agreement in the Precontemplation
Stage of Change, this level of agreement holds different implications than a pair in the
Action/Maintenance Stage of Change of a given ACP behavior.
Future Directions
As the data in the present study are cross-sectional, longitudinal data would
add more information regarding the longevity of a TTM intervention in ACP
behaviors and surrogate readiness to assist their loved ones in the process. TTM data
on ACP support between patients and surrogates assessed at multiple time points is a
future goal for this research.
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This study indicates that Cons, or perceived negative aspects of helping a loved
one in the ACP process, can influence a surrogate’s readiness to participate in the
process. Therefore, it may be important for future studies to work toward better
understanding effective ways to address these perceived negative consequences or
barriers in order to promote surrogate’s helping loved ones in the ACP process.
Schickedanz and colleagues (2009) examined barriers in contemplation,
communication, and documentation ACP behaviors in an old patient sample and
identified 20 self-reported barriers associated with ACP completion. These barriers
included 6 themes: perception of ACP as irrelevant, personal barriers, relationship
concerns, information needs, health encounter time, constraints, and problems with
advance directives. These barriers are similar to some Cons in the present study;
however, the findings in the Schickedanz and colleagues (2009) study suggests that
this list may be limited. In future research, it may be beneficial to examine the barriers
identified by Schickedanz and colleagues (2009) as potential predictors of surrogate
Stage of Change in the four ACP behaviors in the present study. This research would
further help physicians understand the potential barriers to ACP that may be important
to address in their consultations with older patients and their surrogates.
Given that previous experiences in medical decision making has been
identified as a factor that may increase a surrogate’s willingness to help a loved one in
ACP (Vig et al., 2007) it may be beneficial to develop a valid and reliable measure of
medical decision-making experience in a surrogate sample. This may provide more
information regarding the importance of this factor in surrogate involvement in ACP.
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Future research needs to further examine gender differences in surrogates’
communication behaviors with older loved ones. This may uncover factors related to
the finding that female surrogates had significantly higher concordance with their
loved one in readiness to discuss the use of interventions at end-of-life. Future studies
examining gender differences in ACP communication behaviors may help health care
providers better understand different communication styles or techniques that work
best for each gender in the context of end-of-life care planning.
Surrogates in the present study were unevenly distributed amongst the Stages
of Change in each ACP behavior and there were very few participants in the earlier
Stages of Change (i.e. ≤ 17). Given that the Stages of Change were not equally
represented and Precontemplation was underrepresented in the surrogate sample, it
may be beneficial to recruit a larger sample that more fully reflects the range of
readiness for ACP behaviors in future studies. This would add more power to the
results overall and would allow researchers to draw more reliable conclusions. In
addition, future research should utilize the TTM-tailored interventions aimed to
improve readiness to complete ACP behaviors or assist a loved one in completing
these behaviors. Longitudinal data should be collected at multiple time points in order
to assess the efficacy of the intervention.
The present study only examined independent variables derived from the
surrogate sample; therefore, future studies may want to examine independent variables
from the older patient sample as well. Future research could examine relationships
between older patient independent variables and surrogate Stages of Change. In
addition, it may be important to examine independent variables from the older patient

36

sample as predictors of older patient and surrogate Discrepancy on Stage of Change in
each behavior. This research may provide more valuable information aimed to guide
health care provider discussions with patients and their loved ones regarding ACP.
Given that the Discrepancy measure provides limited information regarding
surrogate-older patient discordance on readiness to complete ACP behaviors, it may
be beneficial to develop a measure that more accurately describes the nature of the
surrogate-older patient discordance and elucidate more reasons why a discrepancy
may exist on readiness to complete ACP behaviors.
It is important that future research address ways to promote communication
between all involved in end-of-life care planning in order to improve the quality of
health care services. A recent report by the Institute of Medicine (2014) highlights the
growing need for research that can effect change in policy in order to expand the
availability and improve the effectiveness of medical and social services for patients
and their families. This report suggests that research in this area has made recent gains
by identifying the utility of communication technology and recognizing the
importance of family and caregivers in the decision making process; however, there
remains a need for a more patient and family-centered approach to this issue in health
care settings (Institute of Medicine, 2014). Therefore, future research aimed to further
improve individually tailored interventions in ACP is needed to bridge the gap
between research and policy and improve the quality of end-of-life care.
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Table 1
Demographic Variables for Old Patient and Surrogate Samples

Age
Gender
Female
Male
Race
White
Nonwhite

Age

Old Patient Demographics
M
75

SD
7

N

%

222
82

73
27

225
79
Surrogate Demographics
M
60

74
26
SD
13

Gender
Female
Male

N
148
70

%
68
32

Race
White
Non-white

151
67

69
31

Relationship
Spouse
Child
Other

88
92
38

40
42
18

Communication
Daily
167
76
Weekly or less
51
24
Note. M= mean; N= sample size; SD=standard deviation
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Table 2
Frequencies for Stages of Change and Percentage Differences Between
Surrogate and Older Patient Stage of Change in Each of the Four ACP
Behaviors

ACP
Behavior

Stage of
Change

Surrogates
N

Valid%

Older
Patients
N

SurrogateOlder
Patient %
Difference
Valid%

PC
17
7.8
79
26
18.2
C
34
15.7
55
18.1
2.4
Living Will
PR
41
18.9
15
4.9
14
A/M
125
57.6
155
51
6.6
PC
11
5.1
110
36.4
31.3
C
28
12.9
62
20.5
7.6
HCP
PR
52
24
26
8.6
15.4
A/M
126
58.1
104
34.4
23.7
PC
14
6.5
75
25.3
18.8
C
18
8.3
26
8.8
0.5
Interventions
PR
35
16.1
15
5.1
11
A/M
150
69.1
180
60.8
8.3
PC
14
6.5
114
38.6
32.1
C
17
7.9
30
10.2
2.3
Quality vs.
Quantity of Life
PR
35
16.4
8
2.7
13.7
A/M
148
69.2
143
48.5
20.7
Note. HCP= health care proxy; all percentages are presented as absolute values
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Table 3
Descriptive Statistics for the Level of Discrepancy Between Surrogate and
Older Patient Stages of Change in Four ACP Behaviors
ACP Behaviors

N

Min

Max

M

SD

Living Will

217

0.00

3.00

1.41

1.14

HCP

215

0.00

3.00

1.53

1.10

Interventions

210

0.00

3.00

1.18

1.23

Quality vs.
205
0.00
3.00
1.80
1.23
Quantity of Life
Note. HCP= health care proxy; M= mean; N= sample size; SD=standard deviation
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Table 4
Cronbach’s Alphas for Life Experience, AVCB, and Pros and Cons
# of
α
items
Life Experience
6
12
9.86
1.48
6
0.48
AVCB
7
28
10.70
3.68
7
0.86
Pros
14
30
27.04
3.04
6
0.88
Cons
6
29
11.95
4.93
6
0.84
Note. SD= standard deviation; M= mean; α= Chronbach’s alpha AVCB= attitudes,
values, and cultural beliefs
Measure

Min

Max

M

41

SD

Table 5
Correlations Amongst Surrogate Pros, Cons, AVCB, and Life Experience

Pros
Cons
AVCB
Life Experience

Pros
--0.46**
-.48**
-.18*

Cons

AVCB

-.44**
0.1

-0.04

Note: ** Correlation is significant at the 0.01 level (2-tailed). * Correlation is
significant at the 0.05 level (2-tailed); T-scores for Pros, Cons, and AVCB were
used in analyses; AVCB= attitudes, values, and cultural beliefs.
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Table 6
ANOVAs between Living Will Stages of Change on Pros, Cons, and AVCB
Measures

df

F

η²

p

3
8.99
.114
<.001**
Pros
3
22.13
.225
<.001**
Cons
3
3.34
.049
.020*
AVCB
Note. *p< .05; **p<.01; AVCB= attitudes, values, and cultural beliefs
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Table 7
ANOVAs between HCP Stages of Change on Pros and Cons
Measures

df

3
Pros
3
Cons
Note. *p< .05; **p<.01

F

η²

p

8.99
22.13

.114
.225

.003**
<.001**
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Table 8
ANOVAs between Interventions Stages of Change on Pros and Cons
Measures

df

3
Pros
3
Cons
Note. *p< .05; **p<.01

F

η²

p

7.17
15.36

.093
.191

<.001**
<.001**
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Table 9
ANOVAs between Quality versus Quantity of Life Stages of Change on Pros and Con
Measures

df

3
Pros
3
Cons
Note. *p< .05; **p<.01

F

η²

p

6.25
19.75

.083
.234

<.001**
<.001**
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Table 10
Summary of Multiple Regressions for Surrogate Stage of Change in Four ACP
Behaviors
ACP Behaviors
R²

Predictors

β

t

p

CI (95%)

Pros
Cons
AVCB

-.008
-.494
.032

-.107
-6.525
.420

.915
<.001**
.675

-.015-.014
-.060- -.032
-.012- .018

HCP
R²= .103

Pros
Cons

.001
-.321

.009
-4.112

.993
<.001**

-.013- .013
-.039- -.014

Interventions
R²=.187

Pros
Cons

.096
.377

1.288
-5.085

.199
<.001**

-.004- .020
-.044- -.019

Living Will
R²= .228

Pros
.017
.236
.814
-.011- .013
Quality versus
Quantity of Life Cons
-.458
-6.275
<.001**
-.049- -.026
R²=.218
Note. **p< .01; *p< .05; β = standardized coefficient; CI = confidence interval; HCP=
health care proxy
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Table 11
ANOVA for Gender on Surrogate-Older Patient Discrepancy on Stage of
Change in the Interventions Behavior
Surrogate
Variable

df

1
Gender
Note. *p< .05; **p<.01

F

η²

p

5.95

.028

.016*
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Table 12
Correlations Between Continuous Surrogate Variables and Surrogate- Older
Patient Discrepancy in Readiness to Complete Four ACP Behaviors
Surrogate
Variables

Living Will

HCP

Quality vs.
Quantity
of Life
Age
.140*
.077
.111
.010
Life Experience
-.115
-.022
.121
.030
Pros
-.026
-.033
-.559**
-.080
Cons
.035
-.092
.246**
-.218**
AVCB
.050
.075
.307**
-.043
Note. **Correlation is significant at the .01 level (2-tailed); *Correlation is
significant at the .05 level (2-tailed); HCP= health care proxy; AVCB= attitudes,
values, and cultural beliefs.
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Interventions

Figure 1. Pros, Cons, and AVCB by Surrogate Stage of Change in Four ACP
Behaviors
Living Will

HCP

70

70

65

Pros

65

Pros

60

Cons

60

Cons

55

AVCB

55

AVCB

50

50

45

45

40

40

35

35
PC

C

PR

PC

A/M

C

PR

A/M

Quality vs. Quantity of Life

Interventions
70

70

65

Pros

65

Pros

60

Cons

60

Cons

55

AVCB

AVCB

55
50

50

45

45

40

40

35

35
PC

C

PR

A/M

PC

C

PR

A/M

Figure 1. Line graph showing the distribution of mean T-scores of Pros, Cons, and
AVCB across Stage of Change in four ACP behaviors. Stages of Change include
Precontemplation (PC), Contemplation (C), Preparation (PR), Action/Maintenance
(A/M).
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Figure 2. Percentages of Surrogate and Older Patient Stage of Change in Four ACP
Behaviors
HCP

Living Will
70

70

60
50
40

60
Surrogates

50

Older Patients

40

30

30

20

20

10

10

0
C

PR A/M

PC

Interventions
70

60

60
Surrogates

50

Older Patients

40

30

30

20

20

10

10

0

0
PC

C

C

PR A/M

Quality vs. Quantity of Life

70

40

Older Patients

0
PC

50

Surrogates

Surrogates
Older Patients

PC

PR A/M

C

PR A/M

Figure 2. Bar graph showing the percentages of surrogates and older patients in each
Stage of Change in four ACP behaviors. Stages of Change include Precontemplation
(PC), Contemplation (C), Preparation (PR), Action/Maintenance (A/M).
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Appendices A-D
A. LIFE EXPERIENCE
1.

2.

3.

4.

5.

6.

Have you ever faced a life-threatening illness?

Have you ever had a risky or major surgery?

Have you ever had to make a medical decision for someone who
was dying?

Have you ever known someone who you believe had a bad death
because he/she received too much medical care?

Have you ever known someone who you believe had a bad death
because he/she received too little medical care?

Have you experienced the death of a loved one who made
his/her wishes about end-of-life care known?
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Yes

-1

No

-2

Yes

-1

No

-2

Yes

-1

No

-2

Yes

-1

No

-2

Yes

-1

No

-2

Yes

-1

No

-2

B. ADVANCE CARE PLANNING - PROS AND CONS
Let us take a moment to review what advanced care planning Consists of: 1) Living
Will, 2) Health Care Proxy, 3) Talking to your loved ones and doctor about medical
care you do or do not want to receive at the end-of-life.

2.

6.

8.

Doesn’t
Understand
Question

Strongly
Disagree

Disagree

Agree nor
Disagree

Agree

How strongly do I agree that?

Strongly
Agree

Here are some possible advantages and disadvantages of planning for your future
medical care in the ways that I just asked you about. Please tell me how much you
agree or disagree with these statements. Please choose your answer from a scale of 1
to 5, where 1 means strongly agree, 2 means agree, 3 means neither agree nor
disagree, 4 means disagree and 5 means strongly disagree. Now, some of these
questions may not be clear to you, if so please respond with “I do not understand the
question” as your response.

It would be hard to help my
loved one do advanced care
planning because I don’t like
thinking about him/her being
very ill.

1

2

3

4

5

9

I don’t want to talk with my
loved one about end-of-life
decisions.

1

2

3

4

5

9

It would be hard to help my
loved one do advanced care
planning because there are
1
too many options to Consider
for my loved one’s end of life
care.

2

3

4

5

9

5

9

11. Understanding my loved
one’s wishes would help me
to ensure he/she would get
the care he/she wants.

1

2
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3

4

ADVANCE CARE PLANNING - PROS AND CONS (Continued)
12. I would feel better knowing
my loved one has done what
he/she can to plan for his/her
future.

1

2

3

4

5

9

14. Doing advanced care
planning would make sure
that my loved one got the
1
kind of end of life care he/she
wants.

2

3

4

5

9

15. My loved one does not want
to talk about his/her end of
life care.

1

2

3

4

5

9

16. I would feel better knowing
my loved one is making
his/her wishes clear for the
future.

1

2

3

4

5

9

17. Helping my loved one do
advanced care planning
would go against his/her
lifestyle of taking one day at
a time.

1

2

3

4

5

9

18. Helping my loved one do
advanced care planning
would give me peace of
mind.

1

2

3

4

5

9

23. It would be too hard on my
loved one to plan for his/her
future care.

1

2

3

4

5

9

24. Advanced care planning
would help my loved one to
keep control over what
happens to him/her at the end
of life.

1

2

3

4

5
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C. ADVANCE CARE PLANNING- ATTITUDES VALUES AND BELIEFS

5.

7.

8.

9.

My loved one does not need to do
advance care planning because once
it becomes clear that you are dying,
the doctors aren’t going to use
machines.
My loved one does not need to do
advance care planning because
his/her doctor knows what he/she
wants for end of life care.
My loved one does not need to do
advance care planning because
he/she is most likely not going to
face any hard health care decisions.
My loved one does not need to do
advance care planning because
he/she will always be able to make
his/her own treatment decisions
when the time comes.
Advance care planning would
interfere with the plans that the Lord
has for my loved one.

12. Planning future medical care only
makes sense for those who are much
older or sicker than my loved one

2

3

4

5

9

1

2

3

4

5

9

1

2

3

4

5

9

1

2

3

4

5

9

1

2

3

4

5

9

1

2

3

4

5

9

1

2

3

4

5

9
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Strongly
Disagree

1

Disagree

Neither
Agree nor
Disagree

4.

My loved one doesn’t need advance
care planning because once you
reach a certain age, doctors aren’t
going to use machines.

Agree

3.

Strongly
Agree

How strongly do I agree that:

Doesn’t
Understand
Question

Here are some additional beliefs about issues related to advance care planning. Please
tell me how strongly you agree with the following statements, continuing to use the same
answer categories. Now, some of these questions may not be clear to you so please
respond with “I do not understand the question” as your response.

D. STEPS FOR ADVANCED CARE PLANNING
Now we will talk about the specific steps involved in advanced care planning and what
steps your loved one has taken.

1.

A living will is not the same as a regular will. This is a piece of paper that
generally includes a statement saying that if a person’s condition is thought to be
terminal or if the person is permanently unconscious, then the person should not
be kept alive through life support systems.
Has your loved one made out a living will?

1a.

1b.

GO TO Q. 2←Yes

-1

GO TO Q. 1b←No

-2

Don’t know

-8

Yes

-1

GO TO Q.2←No

-2

Are you ready to ask your loved one if he/she
has a living will?

How ready are you to help your loved one complete a living
will
(if he/she doesn’t have one)?
I am not ready to help my loved one complete a living will

-1

I am thinking about helping my loved one complete a living will

-2

in the next 6 months
I am planning to help my loved one complete a living will in the

-3

next 30 days
NA

2.

-9

Naming a health care proxy means that you have decided on the person you want
to make medical decisions for you if you cannot make them yourself and filling
out a form saying that this person is your choice.

Has your loved one named a health care
proxy?
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GO TO Q. 3 ←Yes

-1

GO TO Q. 2b← No

-2

Don’t know

-8

STEPS FOR ADVANCED CARE PLANNING (Continued)
2a.

2b.

Are you ready to ask your loved one if he/she has a health Yes
care proxy?
GO TO Q. 3 ←No

-1
-2

How ready are you to help name your loved one to name a health care proxy
(if he/she hasn’t named one)?
I am not ready to help my loved one name a health care proxy

-1

I am thinking about helping my loved one name a health care proxy in the

-2

next 6 months
I am planning to help my loved one name a health care proxy in the next

-3

30 days
NA
3.

Are you aware that when people get sick, there are machines that can be used to
keep them alive, such as a breathing machine?
Yes
-1
GO TO Q.4 ←No

3a.

Have you ever talked with your loved one about whether he/she would want
to be kept alive on a machine if he/she was very sick?
GO TO Q. 4 ←Yes
No

3b.

-9

-2

-1
-2

How ready are you to talk to your loved one about this situation?
I am not ready to help my loved one name a health care proxy

-1

I am thinking about helping my loved one name a health care proxy in the

-2

next 6 months
I am planning to help my loved one name a health care proxy in the next

-3

30 days
NA
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-9

STEPS FOR ADVANCED CARE PLANNING (Continued)
4.

Are you aware that some people do not want to live as long as possible if they
have a poor quality of life?
Yes
GO TO NEXT PAGE, PROS AND CONS←
←No

4a.

-2

Have you ever talked with your loved one about whether he/she would want to
live as long as possible if he/she had a poor quality of life?
-1
GO TO NEXT PAGE ←Yes
No

4b.

-1

-2

How ready are you to talk to your loved one about this situation?
I am not ready to talk to my loved one about this situation

-1

I am thinking about in the next 6 months

-2

I am planning to in the next 30 days

-3
NA
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